Pfizer Inc. (PFE)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 5 |
| Ownership rank: | 93 |
| % of all portfolios: | 0.147% |
| Hold Price * : | $26.16 |
| Total insider Buys/Sells last 6 months: |
| Transactions | Total |
| Buys |
2 |
$527,312 |
| Sells |
1 |
$64,825 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
| ≡ |
Kahn Brothers Group |
4.39 |
Reduce 23.66% |
761,090 |
20,192,000 |
| ≡ |
Hillman Value Fund |
2.74 |
Reduce 31.78% |
150,900 |
3,988,000 |
| ≡ |
Richard Pzena - Hancock Classic Value |
2.49 |
Reduce 6.19% |
674,467 |
17,091,000 |
| ≡ |
Prem Watsa - Fairfax Financial Holdings |
1.11 |
Add 41.22% |
650,900 |
17,275,000 |
| ≡ |
David Katz - Matrix Asset Advisors |
0.89 |
Add 25.87% |
318,813 |
8,079,000 |
Open Market Insider Buys
| Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
| 14 Feb 2025 |
BLAYLOCK RONALD E |
Director |
13 Feb 2025 |
19,457 |
25.65 |
499,072 |
| 31 Oct 2024 |
GOTTLIEB SCOTT |
Director |
30 Oct 2024 |
1,000 |
28.24 |
28,240 |
| 19 Dec 2023 |
GOTTLIEB SCOTT |
Director |
15 Dec 2023 |
3,000 |
26.47 |
79,401 |
| 09 May 2023 |
GOTTLIEB SCOTT |
Director |
08 May 2023 |
1,000 |
38.58 |
38,580 |
| 09 May 2023 |
GOTTLIEB SCOTT |
Director |
05 May 2023 |
1,000 |
38.42 |
38,425 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock